Ozempic and Rybelsus are FDA-approved for controlling blood sugar levels in patients with type 2 diabetes
Given the track record of plan sponsors liking to hold on to rebates, its far from clear whether they will pass these on to patients
When these outcomes appear soon after starting a GLP-1 medication, they may point to a preventable adverse drug reaction rather than coincidence
Perez-Lloret S, Negre-Pages L, Damier P, Delval A, Derkinderen P, Destee A, Meissner WG, Tison F, Rascol O, of the CSG (2017) L-DOPA-induced dyskinesias, motor fluctuations and health-related quality of life: the COPARK survey
Despite unanswered questions, health insurers should prepare for increasing interest in and demand for GLP-1s
Roche, Branchburg, NJ, USA), each specimen was diluted to 500, 250, and 125 IU/ml